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A series of nowl cbromone/aza-chromone fused u-aminophosphonate derivatives were synthesized in good yields using
silica chloride as the catalyst. All the synthesized compounds were tested for their c-Src kinase inhibitory activity. Aza..
chromone compound showed Src kinase inhibition with an ICso value of 15.8 µM. The compounds were subjected to
molecular docking and dynamics simulations to study the atomic level interactions with an unphosphorylated protooncogenic tyrosine protein kinase Src (PDB code 1Y57) as well as phosphorylated tyrosine protein kinase Src (PDB code
2H8H). Docking and molecular dynamic results revealed phosphorylated Src tyrosine kinase protein better results than
unphosphorylated tyrosine Src kinase protein. Chemoinformatics study revealed the compounds had lead like properties.
Machine learning (SVR) models were built to study the structure activity correlations. A CC of 0.835 was obtained when the
SVR model was applied to the 17 synthesized compounds. It is envisaged that the work will provide guidelines for future
drug design efforts for Src kinase inhibitors.
Keywords: Phosphorylated cSrc kinase, Cromone Com.pounds, Correlations, Tyrosine Kinase Protein, Proto-Oncogenic

Introduction
Src tyrosine kinase overexpression is regularly
implicated in number of cancer diseases, such as
colon, lung, breast, prostate, ovary and pancreas 1•
There has been raising interest in the development of
Src kinase inhibitors in recent years, both for their use
as research probes, delineating the specific functions
of these kinases, and as potential anticancer/related
therapeutics. Chromone is well recognized as a
privileged motif, due to its abundance in various
natural products with wide range of biological
properties that include anti-bacterial, antifungal, anticancer, anti-HIV and anti-ulcer agents2•3 • Similarly, a.aminophosphonates and a-amino phosphonicacids
constitute an important group of naturally occurring
compounds that are considered as isoelectronic
analogues of the natural a-amino acids. Recently,
coumarin and chromone derivatives have also been
evaluated for their Src kinase inhibition4 . However,
chromone/azachrom.one fused a-aminophosphonate
*Author for Correspondence
E-mail: renu. vyas@mituniversity.edu.in

conjugates have not been studied as Src kinase
inhibitors. In this context, and in view of our
long-standing interest in the chemistry of privileged
5
chromone motif for various biological applications ,
in the present study, we report the synthesis of
chromone/azachromone fused a-amino phosphonate
conjugates. This study also provides insights on
the structure activity relationship as well as the Src
kinase interaction with these compounds using
molecular modeling and molecular dynamics simulation
studies.
Methodology
Synthesis

Synthesis of the targeted compounds is shown
in Figure 1. Commercially available 2-hydroxy..
acetophenone/2- aminoacetophenone was subjected
under Vilsmier condition as per the reported procedure
to obtain the key intermediate 3.. chromone carboxaldehyde/ 3- azacbromone carboxaldehyde. Further,
these aldehydes on condensation with different
amines and diethyl phosphite in presence of silica
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silica chloride
EtOH,60°C
8·12h

1a X•O

1b X•NH

41(85%,8h}
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ld(35%, 12h)

.C.(10%.12h)

~
4f(S0%.10h)

4i(18%.1Zh)

'8t78%.10h)

4n (75%, 10 h)

Ao(72%. 12 h)

. . (85%.Sh)

Fig. 1 - Silica chloride- catalyzed one pot three component synthesis of a-aminophosphonates (4a-4q)

chloride provided chromone/azachromone fused aaminophosphonates6'7.
Most of the compounds were obtained in good
yields with reaction time of 8-12 hours. It should be
noted that when this three component reaction was
performed in the absence of silica chloride, no
product formation was observed. The structures of
the compounds were confirmed by 1H NMR, 13C
NMR and mass spectral analysis8 •
Biological evaluation

Phosphate esters, carboxylic acids, and tetrahedral
intermediates are present in the metabolic and
signaling pathways. Phosphonates have the ability to
structurally mimic the above organic compounds, thus
serving as a small-molecule inhibitor of multiple
processes9 • Phosphonates are used as enzyme
inhibitors, potent antifungal, herbicidal, antiparasitic,
or antimicrobial agents. Glyphosate is the active
ingredient in commercial herbicide and inhibits 5enolpyruvylshikimic acid 3-phosphate synthase

(ESPS) which is critical in the biosynthesis of
aromatic amino acids in plants 10 • All the synthesized
compounds were screened for their Src kinase
inhibitoiy activity. The minimum inhibitoiy concentration
(MIC: µg/ mL) was determined for each compound.
Most of the compounds failed to produce very good
inhibition homomeric compounds 4c & 4o showed
moderate activity with IC 5o = 40.6 & 63.6 µg/ mL.
One of the compound 4j showed good Src kinase
inhibition with IC 5o value of 15.8 µg/ mL.
Cell culture assay and cell proliferation assay

Kinases play a key role in a number of
physiological processes and their inhibitors are seen
to exhibit anticancer activity against various human
cancer cell lines 11 • Kinase inhibition assays are widely
used enzyme inhibition screening assays. Similarly
binding constant assay and TR-FRET assay have seen
to have potencies against both Src kinase. Human
ovarian adenocarcinoma cell line SK-OV3 (ATCC no.
HTB-77) and human colon adenocarcinoma HT-29
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(ATCC no. HTB·38) were obtained from American
Type Culture Collection. Cells were grown on 75 cm2
cell culture flasks with EMEM (Eagle's minimum
essential medium), supplemented with 10% fetal
bovine serum, and 1% penicillin/streptomycin
solution ( 10,000 units of penicillin and 10 mg of
streptomycin in 0.9% NaCl) in a humidified
atmosphere of 5% C02, 95% air at 37 °C. Cell
proliferation assay was carried out using CellTiter
96 aqueous one solution cell proliferation assay kit
(Promega, USA).
Preparation of macromolecule

The protein targets retrieved from RCSB Protein
Data Bank were unphosphorylated proto..oncogenic
tyrosine protein kinase Src (PDB code 1Y57)
and phosphorylated tyrosine protein kinase Src (PDB
code 2H8H) which served as docking receptors.
The proteins were fixed for errors in atomic
representations and optimized using Protein Preparation
Wizard Maestro vl0.3 12 • The bond orders were
assigned to residues, hydrogen atoms were added at
pH 7.0. Minimization was carried out using OPLS
2005 force field with a RMSD cutoff value of 0.3A.
Preparation of ligands; The 20 structures of all
compounds i.e. 4c, 4i, 4j, staurosporine and PP2 were
drawn and analyzed by Marvin view. The compounds
were converted to 3D structure ( .pdb) using LigPrep
tool 13 • LigPrep is a Schr5dinger suite tool which is
used to. generate 3D structures from 2D structures,
search tautomers, isomers for compounds and carry
out energy minimization by applying the OPLS 2005
force field.
Molecular docking

The molecular docking was performed and
analyzed via the Glide v6.8 docking tool 14• The
receptor grid was centered based on the active site of
the protein using receptor grid generation tool.
Ligands prepared using LigPrep were flexibly docked
in grid box using Monte Carlo based simulation
algorithm. An extra precision (XP) method was
employed that generated binding poses based on
energy. The favourably docked molecules were
ranked according ·to the Glide Score.
Molecular dynamics simulation

The docked c-Src kinase proteins with compound
4j were subjected to molecular dynamics simulation
with the CHARMM 36 force field in GROMACS 4.6
tool 15• The simulation was minimized using 5000
steps of Steepest Descent method. The system was
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later equilibrated at 300 Kelvin temperature and 1.06
pressures for 200 ps. The time step set was 0.2 fs. The
final production was run for 20ns and the distance,
RMSF and hydrogen bond trajectories were
calculated for the protein-ligand system.
Structure activity correlation models

The 2D descriptors and Principal components were
computed in MOE CCG computing package. The
SVR model was developed using the RapidMiner data
mining program 16 • The construction, validation of the
SVR model was partitioned into three subsets in
70:20: 10 ratio and the model was built by employing
the s·S VR algorithm and radial basis function
(RBF) kernel function, and validated using five-fold
validation technique. The algorithm utilizes three
parameters, viz. cost function (C), kernel gamma (y)
and width of the loss function (s ).

Results and Discussion
Synthesis

Syntheses of the targeted a.-aminophosphonate
derivatives (4a..q) were prepared through a three
component reaction involving aldehydes, amines and
17
phosphites employing Kabachnik-Fields reaction
condition. To the best of our knowledge, no previous
reports using this catalyst for such reaction have been
reported. All the synthesized compounds have been
evaluated for their c-Src kinase inhibitory activity.
The IC 5o value (µM) was determined for each
compound. Staurosporine and PP2 were employed as
the positive controls. Out of the seventeen compounds
screened, three compounds (4c, 4j, 4o) showed
moderate Src kinase inhibition in the range of ICso
values between 15.8--63.6 µM. In particular,
compound 4j, was identified as the potent inhibitor
(1Cs0=15.8 µM) in the series.
Molecular docking analysis

With an objective to explore the binding potential
of the synthesized and tested molecules for Src
tyrosine kinase, we performed docking studies as
shown in Table 1. Among the 17 structures,
compounds 4c, 4i and 4j were mainly investigated
further for docking simulations since they exhibit
higher inhibitory activity as ascertained from their
MIC data. Human c-Src tyrosine kinase is a multidomain protein consisting of 535 amino acids
possessing SH3, SH2 domains followed by a short
N-terminal and C-terminal regulation segment 18 • In
the unphosphorylated structure, the SH2 and SH3
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Table 1 - Molecular docking analysis of phosphorylated and unphosphorylated c-Src kinase tyrosine protein with selected
compounds. The binding energies were calculated using Glide v6.8 docking tool. - : No docking score was obtained
Unphosphorylated Protein: 1Y57
Sr. no

Compound
4c

2
3

4i

4

4p

5

4m

6
7

Staurosporine

4j

PP2

Amino acids involved in
intermolecular interactions
Lys295
Asp404
Asp404
Lys295
Ala390

Met341
Met341

domains lie at a right angle to each other, with only
SH3 domain in contact with the N-terminal lobe 19•
The SH3 domain is bound between SH2 and kinase
domains in this inactive conformation20 • The Cterminal tail folds back to N-terminal, and the active
site is exposed as it is not blocked by the activation
loop21 • Upon phosphorylation of Tyr527 in C-terminal
or Tyr 416 in the activation loop, the SH2 and SH3
domains lie parallel to the N and C lobes forming an
open and closed cleft that determines the access to the
catalytic site22 • Phosphorylation of Tyr 527 down
regulates the kinase activity and phosphorylation of
Tyr 416 is deemed necessary for exhibiting full kinase
activity. The binding site in c-Src protein is an ATP
pocket present in the N-lobe region21 • Compound 4j
and 4c were bound to the Lys295 residue present in
the C-terminal region of the pocket that acts as an
important site for catalysis, binding of a compound to
the terminal inhibits further kinase activity. Docking
against the un-phosphorylated protein (1Y57) showed
that 4j performed better with -5.4 kcal/mol binding
energy as compared to 4c and 4i which displayed -4.5
and -4.4 kcal/mol binding energy respectively and
formed only a single hydrogen acceptor bond· with
Asp404. It is to be noted here that the compound 4j
displayed a similar good docking score of -6.5
kcal/mol with the phosphorylated protein (2H8H) as
well. All the synthesized compounds were docked
into the ATP binding site which is located at a cleft
between the N and C-terminal lobes, flanked by the
hinge region, P-loop, helix a C and the activation
loop. The docked orientations of the 4j compound
with respect to the native ligands imatinib derivative
in unphosphorylated protein (1 Y57) and anilino

GLIDE Score
(kcal/mol)
-4.5
-4.4

-5.4

Phosphorylated Protein: 2H8H
Amino acids involved in
intermolecular interactions
Lys295
Ala390
Lys295
Asn391
Lys295
Ala390
Ser345
Lys295
Ala390

GLIDE Score
(kcal/mol)
-5.0
-4.6

-6.5
-6.10
-4.18

-8.3
-7.6

quinazoline derivative with phosphorylated protein
(2H8H) in the pocket site are depicted in Figures 2a
and 2b respectively. It is to be noted that the isopropyl
aniline and methyl groups of compound 4j and 4p
respectively fit in the pocket regions, whereas the
isopropyl aniline group of compound 4m was
observed to protrude out of the pocket region thereby
leading to a lower binding efficiency. In the docked
conformation of 4p, the methyl group did not fit well
into the active site cavity. These observations indicate
that the para.orientation of the isopropyl group in the
aniline ring in compound 4j may have an important
role in anchoring it within the active site of the
receptor.
Molecular dynamics study

Molecular dynamics studies were performed for
further probing the dynamicity and fluctuations of
ligand at the atomic level in the active sites of the
unphosphorylated protein ( 1Y57) and phosphorylated
protein (2H8H) hereafter referred to as T 1 and T2
respectively. Figure 3a shows the RMSD trajectories
of T 1 and T2. In the case of Tl, the early peak in
RMSD of compound 4j during the initial time scale of
simulation indicates the relaxation of the compound.
It reached equilibration after 3ns, reflecting its
stability in the pocket region. The RMSD trajectory
for T2 was stable with a rise at 3ns, but is observed to
be relaxing back at 13ns. In order to study the
behaviour of the compound in a dynamic environment,
the root mean square fluctuation (RMSF) of protein~
compound complex was performed. The RMSF
trajectory (Figure 3b) was more stable in case of T2
as compared to Tl; this can be attributed to the open
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(a)

(b)

Fig. 2 - (a) Surface view of Compound 4j (pink) and native
ligand (green) in the binding pocket of receptor 1Y57
(Unphosphorylated protein)
(b) Surface view of Compound 4j (pink) and native ligand (green)
in the binding pocket of receptor 2H8H (Phosphorylated protein)
u ..----...--------------------------~--~
01

(a)
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conformation of T 1 causing high fluctuations in the
loop regions. The H-bond distances were calculated
between compound and amino acid residues involved
in intermolecular interactions and molecular dynamics
simulations. The amino group of Lys295 and oxygen
atom of compound 4j moved apart for Tl, whereas
quinoline group of Ala390 and isopropyl aniline
group of the compound 4j separated in T2 during the
course of the simulation, thereby disrupting the
hydrogen bond which was formed during docking.
Rhythmic fluctuation of compound, the amino group
of Lys295 and oxygen group of Ala390 led to
increase in distance, causing dissociation of the
hydrogen bond formed during docking. In compound
4p, the amino group of Ala390 and oxygen atom of
Ser345 moved apart for T2 during the course of the
simulation, thereby disrupting the hydrogen bond
which was formed during docking. The results
revealed that compound 4p moved apart from its
interacting residues similar to compound 4j. The Hbond distance between the compound 4p and
interacting residue were ve:ry high as compared to 4j,
indicating loss of bonding interactions in the active
site region. A hydrogen bond distance profile was
calculated between binding pocket residues and
compound 4j in the entire MD simulation. The
heteroatoms of the compound formed strong level via
electrostatic bonds (1 - 2.5 A) between Leu273, the
atomic molecular dynamics simulations. Some
interesting observations were noted while comparing
the simulation results between T 1 and T2. In the case
of T2, the HB 1 atom of compound 4j and H22 atom
of Ala293. which were at a distance of 2.6 Ainitially
moved apart to a distance of 8.3 Aduring simulations.
(b)
-2H8H PfOt•in fr2J
-

1YS7 ~in{T1J

10

1'iatt••

Fig. 3 - (a) Root Mean Square Deviation of compound trajectory for 2H8H (T2) and 1Y57 (Tl) protein. The RMSD value indicates
stability of compound molecules in the pocket region. (b) .Root Mean Square Fluctuation (RMSF) of protein· compound complex for
2H8H (T2) and 1Y57 (Tl) protein
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Table 2-Statistical results obtained for known Src kinase inhibitors using SVR model (R2= 0.914)

SVR analysis
Dataset
Total
Training set
Test set
Validation set

cc

MAPE

0.956655
0.945926
0.983458
0.999823

0.176301
0.238429
0.06091
0.002656

RMSE
4.087586
4.333623
4.450468
0.001257

Table 3 - Statistical results obtained for 17 compounds using SVR model (R2= 0.835)

SVR analysis
Data set
Total
Training set
Test set
Validation set

cc

MAPE

RMSE

0.835001
0.956363
0.756247
0.833723

0.36019
0.371753
0.451966
0.557296

50.99193
4.141958
84.40276
95.83819

Active site analysis

Dynamics studies revealed that Leu273, Gly274
and Val281 from Glycine rich and P-loop region;
Lys393 from Activation loop and Ala293 from (33 of
the N-terminal lobe may help in understanding the
residues playing crucial role in ligand binding.
Targeting the N-terminal lobe .can inhibit the
regulatory mechanism in Src kinases. Inhibiting
Leu393 present in the regulatory activation loop, may
inactivate tyrosine phosphorylation in Src and other
kinases. The inhibition studies varies between
phosphorylated and unphosphorylated proteins due to
certain conformational changes in the active site
which render (i) displacement of the C helix, which
removes the catalytically important residue from the
active site cleft, (ii) change in the activation loop
adopting an a-helical conformation, which precludes
binding of peptide substrates and also sequesters
Tyrosine residue, making it inaccessible for
phosphorylation, and (iii) constrain in the orientation
of the N and C lobes which may not be optimal for
catalysis. Thus carrying out a molecular modelling
studies against phosphorylated and unphosphorylated
cSrc kinase protein using synthesized chromone
derivatives will help us to develop a better cSrc kinase
inhibitor.
Structure activity correlation model

We extracted ICso data from literature for the
reported Src kinase inhibitors and computed 2D
molecular descriptors and principal components
(Table 2)23 • The 2D PCA plot displays the chemical
space occupied by the newly synthesized compounds
with respect to the known Src inhibitor space. A CC

of 0.835 was obtained when the 17 synthesiz.ed
compounds were applied to the model (Table 3). The
IC 5o of compound 4j predicted was similar to the
value predicted by experimental methods. The clues
obtained from the structure correlations studies and
help in fine tuning the presently synthesized
compounds for further enhancing the bioactivity.
Cbemoinformatics Analysis

A drugability check was performed for all the
17 synthesized compounds. Lipinski rule of
5 predictions were performed using the Screening
Assistant 2 tool24 • The notion that these compounds
could be further developed as anti-cancer compounds
was further assisted by ADME properties predicted
using PreADMET software25 • The selected compound
4j prioritized in this study fulfilled the above criteria
indicating that it may be further developed in an oral
dosage form. TPSA (Topological polar surface area)
results indicated satisfactory values for all the
17 compounds26 • Thus most synthesiz.ed compounds
predicted favorable ADME predictions. LAZAR
(Lazy structure activity relationships) software detects
carcinogenic properties based on the similarities in
functional group with carcinogenic compounds
present in the Lazar database27 •
Conclusion
In summary, a series of chromone/azachromone
fused a-aminophosphonate conjugates have been
synthesized using silica chloride as a new catalyst. All
the synthesized compounds were evaluated for their cSrc kinase inhibitory activity and one of the
compounds 4j was found to be effective with an IC 5o
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value of 15.8 µM. The stability and convergence of
dynamics results for the phosphorylated and
unphosphorylated proteins with 4j compound in the
simulations establishes its potential as an efficient
inhibitor. Thus docking and dynamics studies
revealed the compound to be more effective against
the phophorylated form of Src kinase. Results also
showed that Leu273, Gly274 and Val281 from
Glycine rich and P-loop region; Lys393 from
Activation loop and Ala293 from ~3 of the N-tenninal
lobe could be considered as potential binding sites for
cSrc kinase proteins.
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